Smith & Nephew releases full-year report, appoints new CEO

British medtech company Smith & Nephew is on the rise on the London stock exchange, following a full-year report and announcement that a Siemens Healthineers manager has been brought in as CEO replacement.
Smith & Nephew competes with Danish firm Coloplast on the wound care market | Photo: Stine Bidstrup/JP
Smith & Nephew competes with Danish firm Coloplast on the wound care market | Photo: Stine Bidstrup/JP
by marketwire, translated by daniel pedersen

On Tuesday, British medtech company Smith & Nephew, a competitor of Coloplast within wound care, has announced a CEO replacement in connection with the release of its full-year financial figures. The double news has been rewarded well on the London stock exchange, sending the company up by 2.1 percent to GBP 12.04.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading